Geneviève Gallagher

786 total citations
14 papers, 465 citations indexed

About

Geneviève Gallagher is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Geneviève Gallagher has authored 14 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Oncology. Recurrent topics in Geneviève Gallagher's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Geneviève Gallagher is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Geneviève Gallagher collaborates with scholars based in Canada, United States and Australia. Geneviève Gallagher's co-authors include Donna L. Forrest, Kirk R. Schultz, Stephanie J. Lee, Stephen Couban, Félix Couture, Gizelle Popradi, David Szwajcer, Tony Panzarella, Mohamed Elemary and Holly Kerr and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Geneviève Gallagher

13 papers receiving 460 citations

Peers

Geneviève Gallagher

HEMAT

IMMUN

PHEOH

ONCOL

EPIDE

Toshiro Kawakita Japan

M A Kharfan-Dabaja United States

Weihua Zhai China

Cristina Barrenetxea Spain

Julie Arrazi United Kingdom

Naofumi Matsuno Japan

Qiaoling Ma China

Mateja Kralj Juric Austria

C. Arthur United Kingdom

Alexandra Laberko Russia

Toshiro Kawakita Japan

Geneviève Gallagher

319 ×0.9

HEMAT

105 ×0.8

IMMUN

118 ×1.1

PHEOH

75 ×0.7

ONCOL

60 ×0.7

EPIDE

Citations per year, relative to Geneviève Gallagher Geneviève Gallagher (= 1×) peers Toshiro Kawakita

Countries citing papers authored by Geneviève Gallagher

Since Specialization

Citations

This map shows the geographic impact of Geneviève Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneviève Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneviève Gallagher more than expected).

Fields of papers citing papers by Geneviève Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geneviève Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneviève Gallagher. The network helps show where Geneviève Gallagher may publish in the future.

Co-authorship network of co-authors of Geneviève Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Geneviève Gallagher. A scholar is included among the top collaborators of Geneviève Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geneviève Gallagher. Geneviève Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Deschênes‐Simard, Xavier, Frédéric Barabé, Vinçent Laroche, et al.. (2024). Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study. Leukemia & lymphoma. 65(13). 1974–1982. 2 indexed citations

Walker, Irwin, Mohamed Elemary, Mahmoud Elsawy, et al.. (2024). A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT). Blood. 144(Supplement 1). 3519–3519.

Barabé, Frédéric, Vinçent Laroche, Geneviève Gallagher, et al.. (2022). Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study. Blood. 140(Supplement 1). 3304–3305. 1 indexed citations

Walker, Irwin, Tony Panzarella, Stephen Couban, et al.. (2020). Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. The Lancet Haematology. 7(2). e100–e111. 53 indexed citations

Roy, Jean, Tony Panzarella, Stephen Couban, et al.. (2019). Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial. Blood. 134(Supplement_1). 875–875. 1 indexed citations

Rozmus, Jacob, Sabine Ivison, Amina Kariminia, et al.. (2018). Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD. Bone Marrow Transplantation. 53(10). 1263–1269. 12 indexed citations

Walker, Irwin, Tony Panzarella, Stephen Couban, et al.. (2015). Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. The Lancet Oncology. 17(2). 164–173. 236 indexed citations

Côté, Julie Anne, Guy Cantin, Julie Lemieux, & Geneviève Gallagher. (2014). Allogeneic stem cell transplantation (SCT) using a CAT-bu conditioning regimen in patients with advanced myelodysplastic/myeloproliferative disorders (MDS-MPDs).. Journal of Clinical Oncology. 32(15_suppl). 7035–7035. 1 indexed citations

Walker, Irwin, Kirk R. Schultz, Cynthia L. Toze, et al.. (2014). Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial. Blood. 124(21). 38–38. 12 indexed citations

10.

Gallagher, Geneviève, Douglas E. Horsman, Peter Tsang, & Donna L. Forrest. (2008). Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders. Cancer Genetics and Cytogenetics. 181(1). 46–51. 22 indexed citations

11.

Gallagher, Geneviève & Donna L. Forrest. (2006). Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer. 109(1). 84–92. 54 indexed citations

12.

Gallagher, Geneviève, et al.. (2001). A candidate gene study in predicted severe acute pancretitis. Gastroenterology. 120(5). A468–A468. 2 indexed citations

13.

Eskdale, Joyce, et al.. (2001). Fine genomic mapping implicates IL-10 as a severity gene in acute pancreatitis. Gastroenterology. 120(5). A24–A24. 1 indexed citations

14.

Meade, John C., et al.. (1987). Structure and Expression of a Tandem Gene Pair in Leishmania donovani That Encodes a Protein Structurally Homologous to Eucaryotic Cation-Transporting ATPases. Molecular and Cellular Biology. 7(11). 3937–3946. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact